2921 Stock Overview

An investment holding company, primarily engages in the provision of manpower outsourcing and ancillary services to building and construction contractors in Singapore. More details

2921 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Risk Analysis

Shares are highly illiquid

Earnings have declined by 58.7% per year over past 5 years

My Notes

Capture your thoughts, links and company narrative

Jinhai Medical Technology Limited Competitors

Television Broadcasts

SEHK:511

HK$1.4b

Be Friends Holding

SEHK:1450

HK$1.4b

Silkwave

SEHK:471

HK$66.3m

Oriental Enterprise Holdings

SEHK:18

HK$827.3m

Price History & Performance

Summary of share price highs, lows and changes for Jinhai Medical Technology
Historical stock prices
Current Share Price	HK$1.70
52 Week High	HK$2.20
52 Week Low	HK$1.50
Beta	0.052
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-15.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	2921	HK Professional Services	HK Market
7D	-15.0%	-4.7%	-0.9%
1Y	n/a	18.3%	19.2%

Return vs Industry: Insufficient data to determine how 2921 performed against the Hong Kong Professional Services industry.

Return vs Market: Insufficient data to determine how 2921 performed against the Hong Kong Market.

Price Volatility

Is 2921's price volatile compared to industry and market?
2921 volatility
2921 Average Weekly Movement	n/a
Professional Services Industry Average Movement	9.1%
Market Average Movement	8.9%
10% most volatile stocks in HK Market	18.7%
10% least volatile stocks in HK Market	4.1%

Stable Share Price: 2921's share price has been volatile over the past 3 months compared to the Hong Kong market.

Volatility Over Time: Insufficient data to determine 2921's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2006	508	Zhenfei Wang	www.jin-hai.com.hk

Jinhai Medical Technology Limited, an investment holding company, primarily engages in the provision of manpower outsourcing and ancillary services to building and construction contractors in Singapore. The company also provides dormitory services; information technology services; and construction ancillary services comprising warehousing and cleaning services, and building maintenance works. In addition, it engages in the engineering design and consultancy activities, and accommodation for foreign workers dormitory providers; is involved in the provision of minimally invasive surgery solutions, medical products, and related services, as well as sales of medical equipment; and graphene material products.

Jinhai Medical Technology Limited Fundamentals Summary

How do Jinhai Medical Technology's earnings and revenue compare to its market cap?
2921 fundamental statistics
Market cap	HK$8.53b
Earnings (TTM)	-HK$57.91m
Revenue (TTM)	HK$340.93m

25.0x

P/S Ratio

-147.3x

P/E Ratio

Is 2921 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2921 income statement (TTM)
Revenue	S$59.60m
Cost of Revenue	S$45.20m
Gross Profit	S$14.40m
Other Expenses	S$24.53m
Earnings	-S$10.12m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.002
Gross Margin	24.17%
Net Profit Margin	-16.99%
Debt/Equity Ratio	19.8%

How did 2921 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/19 23:15
End of Day Share Price	2024/12/19 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jinhai Medical Technology Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution